The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies

Colorectal cancer (CRC) is one of the most frequent tumor entities worldwide with only limited therapeutic options. CRC is not only a genetic disease with several mutations in specific oncogenes and/or tumor suppressor genes such as APC, KRAS, PIC3CA, BRAF, SMAD4 or TP53 but also a multifactorial di...

Full description

Bibliographic Details
Main Authors: Heidi Braumüller, Bernhard Mauerer, Johanna Andris, Christopher Berlin, Thomas Wieder, Rebecca Kesselring
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/12/1/138
_version_ 1797626026691395584
author Heidi Braumüller
Bernhard Mauerer
Johanna Andris
Christopher Berlin
Thomas Wieder
Rebecca Kesselring
author_facet Heidi Braumüller
Bernhard Mauerer
Johanna Andris
Christopher Berlin
Thomas Wieder
Rebecca Kesselring
author_sort Heidi Braumüller
collection DOAJ
description Colorectal cancer (CRC) is one of the most frequent tumor entities worldwide with only limited therapeutic options. CRC is not only a genetic disease with several mutations in specific oncogenes and/or tumor suppressor genes such as APC, KRAS, PIC3CA, BRAF, SMAD4 or TP53 but also a multifactorial disease including environmental factors. Cancer cells communicate with their environment mostly via soluble factors such as cytokines, chemokines or growth factors to generate a favorable tumor microenvironment (TME). The TME, a heterogeneous population of differentiated and progenitor cells, plays a critical role in regulating tumor development, growth, invasion, metastasis and therapy resistance. In this context, cytokines from cancer cells and cells of the TME influence each other, eliciting an inflammatory milieu that can either enhance or suppress tumor growth and metastasis. Additionally, several lines of evidence exist that the composition of the microbiota regulates inflammatory processes, controlled by cytokine secretion, that play a role in carcinogenesis and tumor progression. In this review, we discuss the cytokine networks between cancer cells and the TME and microbiome in colorectal cancer and the related treatment strategies, with the goal to discuss cytokine-mediated strategies that could overcome the common therapeutic resistance of CRC tumors.
first_indexed 2024-03-11T10:04:46Z
format Article
id doaj.art-41ea724702614176aefd57980ed8b55a
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-11T10:04:46Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-41ea724702614176aefd57980ed8b55a2023-11-16T15:06:36ZengMDPI AGCells2073-44092022-12-0112113810.3390/cells12010138The Cytokine Network in Colorectal Cancer: Implications for New Treatment StrategiesHeidi Braumüller0Bernhard Mauerer1Johanna Andris2Christopher Berlin3Thomas Wieder4Rebecca Kesselring5Department of General and Visceral Surgery, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, GermanyDepartment of General and Visceral Surgery, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, GermanyDepartment of General and Visceral Surgery, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, GermanyDepartment of General and Visceral Surgery, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, GermanyDepartment of Vegetative and Clinical Physiology, Institute of Physiology, Eberhard Karls University Tübingen, 72074 Tübingen, GermanyDepartment of General and Visceral Surgery, Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, GermanyColorectal cancer (CRC) is one of the most frequent tumor entities worldwide with only limited therapeutic options. CRC is not only a genetic disease with several mutations in specific oncogenes and/or tumor suppressor genes such as APC, KRAS, PIC3CA, BRAF, SMAD4 or TP53 but also a multifactorial disease including environmental factors. Cancer cells communicate with their environment mostly via soluble factors such as cytokines, chemokines or growth factors to generate a favorable tumor microenvironment (TME). The TME, a heterogeneous population of differentiated and progenitor cells, plays a critical role in regulating tumor development, growth, invasion, metastasis and therapy resistance. In this context, cytokines from cancer cells and cells of the TME influence each other, eliciting an inflammatory milieu that can either enhance or suppress tumor growth and metastasis. Additionally, several lines of evidence exist that the composition of the microbiota regulates inflammatory processes, controlled by cytokine secretion, that play a role in carcinogenesis and tumor progression. In this review, we discuss the cytokine networks between cancer cells and the TME and microbiome in colorectal cancer and the related treatment strategies, with the goal to discuss cytokine-mediated strategies that could overcome the common therapeutic resistance of CRC tumors.https://www.mdpi.com/2073-4409/12/1/138interferoninterleukintumor necrosis factortumor microenvironmenttumor progressiontumor surveillance
spellingShingle Heidi Braumüller
Bernhard Mauerer
Johanna Andris
Christopher Berlin
Thomas Wieder
Rebecca Kesselring
The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies
Cells
interferon
interleukin
tumor necrosis factor
tumor microenvironment
tumor progression
tumor surveillance
title The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies
title_full The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies
title_fullStr The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies
title_full_unstemmed The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies
title_short The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies
title_sort cytokine network in colorectal cancer implications for new treatment strategies
topic interferon
interleukin
tumor necrosis factor
tumor microenvironment
tumor progression
tumor surveillance
url https://www.mdpi.com/2073-4409/12/1/138
work_keys_str_mv AT heidibraumuller thecytokinenetworkincolorectalcancerimplicationsfornewtreatmentstrategies
AT bernhardmauerer thecytokinenetworkincolorectalcancerimplicationsfornewtreatmentstrategies
AT johannaandris thecytokinenetworkincolorectalcancerimplicationsfornewtreatmentstrategies
AT christopherberlin thecytokinenetworkincolorectalcancerimplicationsfornewtreatmentstrategies
AT thomaswieder thecytokinenetworkincolorectalcancerimplicationsfornewtreatmentstrategies
AT rebeccakesselring thecytokinenetworkincolorectalcancerimplicationsfornewtreatmentstrategies
AT heidibraumuller cytokinenetworkincolorectalcancerimplicationsfornewtreatmentstrategies
AT bernhardmauerer cytokinenetworkincolorectalcancerimplicationsfornewtreatmentstrategies
AT johannaandris cytokinenetworkincolorectalcancerimplicationsfornewtreatmentstrategies
AT christopherberlin cytokinenetworkincolorectalcancerimplicationsfornewtreatmentstrategies
AT thomaswieder cytokinenetworkincolorectalcancerimplicationsfornewtreatmentstrategies
AT rebeccakesselring cytokinenetworkincolorectalcancerimplicationsfornewtreatmentstrategies